EFFECT OF TOREMIFENE IN BREAST-CANCER PATIENTS - PRELIMINARY COMMUNICATION

被引：9

作者：

HINDY, I

JUHOS, E

SZANTO, J

SZAMEL, I

机构：

[1] National Institute of Oncology, 1525 Budapest

来源：

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1990年 / 36卷 / 03期

关键词：

D O I：

10.1016/0022-4731(90)90010-P

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Toremifene, an antiestrogenic drug administered at three dose levels (60, 120, and 300 mg/day) was investigated in 17 postmenopausal patients with advanced breast cancer previously treated with hormonal and/or cytostatic therapy. The drug proved to be well tolerated at all dose levels without any serious side effects even on prolonged administration. Neither response nor side effects have shown any dose dependency in this small group of patients. © 1990.

引用

页码：225 / 226

页数：2